Anti-Tnf Biosimilars Indicated for Rheumatoid Arthritis are Increasingly Available in Europe: How Do Payers and Key Stakeholders Perceive Them?
Value Health
.
2014 Nov;17(7):A388.
doi: 10.1016/j.jval.2014.08.2656.
Epub 2014 Oct 26.
Authors
N P S Sewak
1
,
C Jones
1
Affiliation
1
Double Helix Consulting, London, UK.
PMID:
27200886
DOI:
10.1016/j.jval.2014.08.2656
No abstract available